随着全国多地进入流感高发期，公众健康防护再次成为社会焦点。国家卫健委监测数据显示，流感活动水平持续攀升，尤其在儿童及青少年群体中检出 率更高，凸显了科学防治的紧迫性[1]。在这一背景下，早期、有效的抗病毒干预对于缩短病程、降低重症风险、遏制病毒传播同样至关重要。作为深耕 抗病毒领域多年的生物制药企业，科兴制药（688136.SH）始终以创新为驱动，为呼吸道病毒感染防治提供更多样、更便捷的解决方案。 一、 从"广谱"到"精准"：干扰素的抗病毒防线 流感由流感病毒引起，其快速复制和传播能力是导致疾病流行的关键。理想的抗病毒策略之一是尽早激活并强化人体自身的固有免疫防御。干扰素，正 是人体抵御病毒感染的第一道天然防线。当病毒入侵时，细胞会迅速产生干扰素，它通过激活一系列下游效应蛋白，在细胞间建立"抗病毒状态"，从而 抑制病毒的复制与扩散[2]。 人干扰素α1b是中国自主研发的I型干扰素，具有天然、广谱的抗病毒活性和相对温和的免疫调节特性。科兴制药是国内较早从事干扰素研发与生产的企 业，公司核心产品-注射用人干扰素α1b（商品名：赛若金 ）自上市以来，已在临床广泛应用三十载。 二、 赛若金 ：经典可靠的抗病毒"卫士" ...

Group 1 - The company’s subsidiary, Hengtai Wanyang Pharmaceutical, received approval for the chemical raw material drug Dapagliflozin, indicating compliance with national drug registration requirements [1] - Dapagliflozin is a selective SGLT-2 inhibitor used for treating type 2 diabetes by promoting glucose excretion [2] - China has over 118 million diabetes patients, accounting for 22% of the global burden, with the diabetes medication market projected to reach 52.7 billion yuan in 2024, where Dapagliflozin holds a 12.83% market share [3] Group 2 - The market for Dapagliflozin is expected to grow to 7.38 billion yuan in 2025, with a sales volume of 1.78 billion tablets, reflecting a year-on-year growth of 35% and 38% respectively [3] - Dapagliflozin has been included in the national centralized procurement directory, with a price reduction of over 90%, benefiting more patients [3] - The company plans to leverage this domestic approval to accelerate international registration and sales of Dapagliflozin, targeting markets in Europe and the US [3] Group 3 - The company’s subsidiary, Yiling Wanzhou International Pharmaceutical, received approval for the drug Valaciclovir, enhancing the company’s product pipeline [7] - Valaciclovir is an antiviral drug used for treating herpes zoster and simplex virus infections, with a market share of 3.17% in the antiviral drug market projected to reach 4.5 billion yuan in 2025 [9][10] - The increasing incidence of herpes zoster, especially among the aging population, is expected to drive demand for Valaciclovir [10] Group 4 - The company has submitted a clinical trial application for a new traditional Chinese medicine, Qilong Dingchuan Tablets, which has been accepted by the National Medical Products Administration [13] - The proposed indications for Qilong Dingchuan Tablets include treating chronic obstructive pulmonary disease with symptoms such as shortness of breath and cough [16]

Core Viewpoint - The recent emergence of the H3N2 influenza virus has led to increased public concern, with symptoms reported to be more severe than those of a common cold, as indicated by the China CDC's report showing over 90% of positive samples being H3N2 [1] Group 1: Differentiating Between Common Cold and Influenza - Influenza symptoms typically appear suddenly, including high fever, headache, sore throat, cough, significant fatigue, and muscle aches, while common cold symptoms develop more gradually and are generally milder [2] - High fever (above 39°C) lasting 3-5 days is common in influenza, whereas common cold fever is usually below 38°C and resolves within 1-2 days [2] - Early identification of symptoms is crucial for appropriate treatment and resource management [2] Group 2: Recovery Timeline and Potential Aftereffects - Antiviral treatment is most effective when administered within 48 hours of symptom onset, with medications like Oseltamivir and Marbofloxacin recommended [3] - Influenza itself does not typically leave aftereffects, but delayed treatment can lead to serious complications such as pneumonia or myocarditis, which may have long-term health impacts [3] - Healthy adults usually recover from typical influenza symptoms within a week, but some may experience lingering cough and fatigue for up to two weeks [3] Group 3: Preventive Measures for H3N2 Influenza - Vaccination is strongly recommended as the most effective and economical preventive measure against influenza [4][5] - The composition of the flu vaccine is adjusted annually to match circulating strains, enhancing its effectiveness [5] - Public health recommendations include wearing masks in high-risk areas and isolating when symptomatic to prevent the spread of the virus [5]